Duncker Streett & CO Inc Bausch Health Companies Inc. Transaction History

Duncker Streett & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$13.31 - $20.51 $5,324 - $8,204	-400 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$18.89 - $31.89 $7,556 - $12,756	400 New	400 $12,000
Q3 2019 Oct 31, 2019	SELL	$20.88 - $25.66 $8,352 - $10,264	-400 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$20.52 - $26.45 $4,104 - $5,290	-200 Reduced 33.33%	400 $10,000
Q3 2018 Oct 22, 2018	BUY	$20.64 - $25.67 $12,384 - $15,402	600 New	600 $15,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.75B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Duncker Streett & CO Inc with notifications on news.